TARS EPS Estimates
Tarsus Pharmaceuticals, Inc.
$73.93
-$0.18(-0.24%)
53
Overall
40
Value
63
Tech
57
Quality
Market Cap
$3.48B
Volume
150.01K
52W Range
$53.89 - $91.53
Target Price
$98.56
TARS EPS estimates: the consensus estimate for Tarsus Pharmaceuticals, Inc.'s current fiscal year is -$4.25 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
TARS EPS Estimates
- EPS estimate, current quarter
- $-1.49
- EPS estimate, next quarter
- $-3.45
- EPS estimate, current year
- $-4.25
- EPS estimate, next year
- $0.60
- EPS growth, 3-year
- +14.23%
| Fiscal year | EPS |
|---|---|
| 2025 | $-1.59 |
| 2024 | $-3.07 |
| 2023 | $-4.62 |
| 2022 | $-2.52 |
| 2021 | $-0.67 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | TARS | $73.93 | -0.2% | 150.01K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Tarsus Pharmaceuticals, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW